当前位置: X-MOL 学术Annu. Rev. Pharmacol. Toxicol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Autophagy: A Druggable Process
Annual Review of Pharmacology and Toxicology ( IF 12.5 ) Pub Date : 2017-01-06 00:00:00 , DOI: 10.1146/annurev-pharmtox-010716-104936
Etienne Morel 1, 2 , Maryam Mehrpour 1, 2 , Joëlle Botti 1, 3 , Nicolas Dupont 1, 2 , Ahmed Hamaï 1, 2 , Anna Chiara Nascimbeni 1, 2 , Patrice Codogno 1, 2
Affiliation  

Macroautophagy (hereafter called autophagy) is a vacuolar, lysosomal pathway for catabolism of intracellular material that is conserved among eukaryotic cells. Autophagy plays a crucial role in tissue homeostasis, adaptation to stress situations, immune responses, and the regulation of the inflammatory response. Blockade or uncontrolled activation of autophagy is associated with cancer, diabetes, obesity, cardiovascular disease, neurodegenerative disease, autoimmune disease, infection, and chronic inflammatory disease. During the past decade, researchers have made major progress in understanding the three levels of regulation of autophagy in mammalian cells: signaling, autophagosome formation, and autophagosome maturation and lysosomal degradation. As we discuss in this review, each of these levels is potentially druggable, and, depending on the indication, may be able to stimulate or inhibit autophagy. We also summarize the different modulators of autophagy and their potential and limitations in the treatment of life-threatening diseases.

中文翻译:


自噬:可药物化的过程

巨自噬(以下称为自噬)是用于真核细胞中保守的细胞内物质分解代谢的液泡,溶酶体途径。自噬在组织动态平衡,适应压力状况,免疫反应以及调节炎症反应中起着至关重要的作用。自噬的阻滞或不受控制的激活与癌症,糖尿病,肥胖症,心血管疾病,神经退行性疾病,自身免疫性疾病,感染和慢性炎性疾病有关。在过去的十年中,研究人员在了解哺乳动物细胞自噬的三个调节水平方面取得了重大进展:信号传导,自噬小体形成,自噬小体成熟和溶酶体降解。正如我们在这篇评论中讨论的那样,这些水平中的每一个都可能是可药物治疗的,并且 根据适应症,可能能够刺激或抑制自噬。我们还总结了自噬的不同调节剂及其在威胁生命的疾病治疗中的潜力和局限性。

更新日期:2017-01-06
down
wechat
bug